drugset / Trial / NCT04637139

A Study to Evaluate the Mass Balance Absorption and AME of VBR

NCT04637139

Phase 1 Completed 6 enrolled Assembly Biosciences
NaSingle-groupOpen-labelTreatment

Summary

This Phase 1 Study will determine the mass balance recovery, absorption, metabolism, and excretion of \[14C\] Vebicorvir in healthy male subjects

Timeline

Start
2020-12-01
Primary completion
2020-12-22
Completion
2020-12-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Vebicorvir Small molecule 300 mg Oral